全文获取类型
收费全文 | 1762篇 |
免费 | 101篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 49篇 |
儿科学 | 27篇 |
妇产科学 | 11篇 |
基础医学 | 256篇 |
口腔科学 | 18篇 |
临床医学 | 161篇 |
内科学 | 580篇 |
皮肤病学 | 10篇 |
神经病学 | 159篇 |
特种医学 | 33篇 |
外科学 | 227篇 |
综合类 | 9篇 |
预防医学 | 87篇 |
眼科学 | 39篇 |
药学 | 57篇 |
肿瘤学 | 145篇 |
出版年
2024年 | 2篇 |
2023年 | 8篇 |
2022年 | 18篇 |
2021年 | 36篇 |
2020年 | 17篇 |
2019年 | 39篇 |
2018年 | 51篇 |
2017年 | 28篇 |
2016年 | 38篇 |
2015年 | 28篇 |
2014年 | 61篇 |
2013年 | 75篇 |
2012年 | 122篇 |
2011年 | 145篇 |
2010年 | 64篇 |
2009年 | 80篇 |
2008年 | 102篇 |
2007年 | 119篇 |
2006年 | 122篇 |
2005年 | 103篇 |
2004年 | 84篇 |
2003年 | 84篇 |
2002年 | 86篇 |
2001年 | 49篇 |
2000年 | 58篇 |
1999年 | 52篇 |
1998年 | 23篇 |
1997年 | 18篇 |
1996年 | 10篇 |
1995年 | 6篇 |
1994年 | 7篇 |
1992年 | 25篇 |
1991年 | 19篇 |
1990年 | 13篇 |
1989年 | 15篇 |
1988年 | 10篇 |
1987年 | 9篇 |
1986年 | 4篇 |
1985年 | 3篇 |
1984年 | 5篇 |
1983年 | 3篇 |
1981年 | 4篇 |
1979年 | 2篇 |
1977年 | 3篇 |
1975年 | 2篇 |
1974年 | 4篇 |
1972年 | 3篇 |
1968年 | 1篇 |
1964年 | 1篇 |
1963年 | 1篇 |
排序方式: 共有1868条查询结果,搜索用时 15 毫秒
51.
Chamontin B Beaune J Cambou JP Vaisse B Bonnelye G Ricard S Josse L Gallois H 《Archives des maladies du coeur et des vaisseaux》2005,98(7-8):795-799
OBJECTIVE: To evaluate systolic blood pressure (SBP) control in hypertensive patients with a stable coronary heart disease (CHD) in general practice in France. METHODS: A survey was conducted in a sample of 206 general practitionners (GP) representative of the French medical population, in 2003 [LHYCORNE survey]. Each GP had to include 3 hypertensive patients, >18 years old, BP > or = 140/90 mmHg and/or treated for hypertension, and with evidence of CHD documented by myocardial infarction (MI) or angina pectoris (AP) [diagnosis previously established by a cardiologist]. Three office BP measurements were performed, the last two recorded. BP levels were considered as controlled by treatement if they were < 140/90 mmHg. RESULTS: 595 patients were included, 75% men mean age 66 years, 25% women mean age 73 years. All patients had a CHD: MI 46%, AP 54%; 533 (90%) had more than 2 cardiovascular risk factors: hyperlipidemia (411; 69%), smokers (375; 63%), diabetes (158; 27%). Mean BP was 140.7 +/- 14/80.8 +/- 9.7 mmHg; 553 (93%) of these hypertensive patients were treated, and 239 (40%) were considered as having a controlled SBP at the treshold of 140 mmHg: 47% in patients with previous MI and 38% with AP (p < 0.001). Diastolic BP (DBP) was <90 mmHg in 480 (81%) and pulse pressure was >65 mmHg in 202 (34%); 313 (53%) patients received a combination of three drugs or more; 354 (60%) had a beta-blocker, 260 (44%) a calcium channel blocker, 237 (40%) an ACE inhibitor, 287 (48%) other antihypertensive drugs (246 diuretics, 41%); 502 (84%) received antiplatelet therapy, 403 (68%) statins. CONCLUSION: This survey shows that systolic BP is not at goal in 6/10 hypertensive patients with stable CHD suggesting there is a place for a more effective combination therapy according to evidence-based medicine. 相似文献
52.
Ramos-Casals M Mañá J Nardi N Brito-Zerón P Xaubet A Sánchez-Tapias JM Cervera R Font J;HISPAMEC Study Group 《Medicine》2005,84(2):69-80
We describe the clinical characteristics, the patterns of association, and the role of antiviral therapies in patients with sarcoidosis associated with chronic hepatitis C virus (HCV) infection. Sixty-eight patients were included in the current study, 56 cases identified in the literature search plus 12 unpublished cases from our department. In 50 HCV patients, sarcoidosis appeared after starting antiviral therapy. Antiviral therapy associated with triggered sarcoidosis consisted of alpha-interferon monotherapy in 20 cases and combined therapy with alpha-interferon and ribavirin in 30. Sarcoidosis appeared during the first 6 months after starting therapy in 66% of patients. The clinical picture of sarcoidosis included predominantly pulmonary disease in 38 (76%) patients and cutaneous sarcoidosis in 30 (60%). Antiviral therapy was discontinued in 60% of patients and continued or adjusted in 14%, while sarcoidosis appeared after completed therapy in the remaining cases. Specific therapy for sarcoidosis was started in only 21 patients, mainly with oral corticosteroids. The outcome of patients was detailed in 46 cases: remission or improvement was observed in 38/46 (83%) patients, stabilization of sarcoidosis in 5/46 (11%), and reactivation of sarcoidosis after an initial improvement in 3/46 (6%). Finally, 18 treatment-naive HCV patients presented sarcoidosis, with 14/18 (87%) patients presenting with pulmonary involvement and 8/18 (44%) with cutaneous involvement.In summary, sarcoidosis may be observed in HCV patients in 2 different situations: triggered by antiviral therapy (in 75% of cases) and unrelated to treatment. Sarcoidosis during antiviral therapy may present mainly as cutaneous or pulmonary disease, with a benign, uncomplicated evolution in more than 85% of cases. However, more complicated cases are observed, especially in HCV patients with preexisting sarcoidosis and/or with previous antiviral treatment. Clinicians should be aware of the possibility that sarcoidosis may initially manifest or be reactivated during or shortly after treatment with antiviral therapy in patients with chronic HCV infection. 相似文献
53.
de la Rubia J Sanz GF Martín G Martínez J Cervera J Solves P Jiménez C Arnao M Vicente A Jarque I Sempere A Sanz MA 《Haematologica》1999,84(2):125-132
BACKGROUND AND OBJECTIVE: To compare the clinical results of two consecutive therapeutic protocols including autologous blood stem cell transplantation (ABSCT) for patients with de novo acute myeloblastic leukemia (AML) in first complete remission (CR1). DESIGN AND METHODS: Between November 1989 and January 1997, 50 patients with AML in CR1 underwent ABSCT using two consecutive protocols. In the first one (Group A, 25 patients) peripheral blood stem cells (PBSC) were collected after induction and consolidation chemotherapy courses, and ABSCT was performed immediately thereafter. In the subsequent 25 patients (Group B), PBSC were collected after consolidation alone, and a further chemotherapy course with intermediate dose cytarabine (Ara-C 1 g/m2/12 h x3 days) and mitoxantrone (12 mg/m2/d x3 days) was administered as early intensification. The conditioning regimen consisted of busulfan (16 mg/kg) and cyclophosphamide (200 mg/kg) in every case. RESULTS: Hematopoietic engraftment was slightly quicker in Group B, with median times to reach 0.5 x 10(9) neutrophils/L and 20 x 10(9) platelets/L being 13 and 12 days in Group A and 12 and 11 days in Group B, respectively. There were three graft failures (8%) (2 in Group A and 1 in Group B) and three transplant-related deaths (8%) (2 in Group A and 1 in Group B). No significant differences were observed between the groups in terms of relapse (64% at 4-years in Group A and 81% in Group B). Likewise, the actuarial 4-year disease-free survival (DFS) was not significantly different between the two groups (32% v 18%). INTERPRETATION AND CONCLUSIONS: Our study confirms that AML patients in CR1 receiving ABSCT have rapid engraftment with low mortality. However, autologous transplants with PBSC collected after consolidation chemotherapy were still associated with a high rate of relapse (RR). This RR was not apparently reduced by the administration of intermediate dose Ara-C before transplantation. 相似文献
54.
55.
Pere Castellví Carlos G. Forero Miquel Codony Gemma Vilagut Pilar Brugulat Antonia Medina Andrea Gabilondo Anna Mompart Joan Colom Ricard Tresserras Montse Ferrer Sarah Stewart-Brown Jordi Alonso 《Quality of life research》2014,23(3):857-868
Purpose
Mental well-being has aroused interest in Europe as an indicator of population health. The Warwick-Edinburgh Mental Well-Being Scale (WEMWBS) was developed in the United Kingdom showing good face validity and has been previously adapted into Spanish. The aim of this study is to assess the validity and reliability of the Spanish version of WEMWBS in the general population.Methods
Cross-sectional home face-to-face interview survey with computer-assisted personal interviewing was administered with the 2011 Catalan Health Interview Survey Wave 3, which is representative of the non-institutionalized general population of Catalonia, Spain. A total of 1,900 participants 15+ years of age were interviewed. The Spanish version of WEMWBS was administered together with socioeconomic and health-related variables, with a hypothesized level of association.Results
Similar to the original, confirmatory factor analysis fits a one-factor model adequately (CFI = 0.974; TLI = 0.970; RMSEA = 0.059; χ 2 = 584.82; df = 77; p < .001) and has a high internal consistency (Cronbach’s alpha = 0.930; Guttman’s lambda 2 = 0.932). The WEMWBS discriminated between population groups in all health-related and socioeconomic variables, except in gender (p = 0.119), with a magnitude similar to that hypothesized. Overall, mental well-being was higher for the general population of Catalonia (average and whole distribution) than that for Scotland general population.Conclusions
The Spanish version of WEMWBS showed good psychometric properties similar to the UK original scale. Whether better mental well-being in Catalonia is due to methodological or substantive cultural, social, or environmental factors should be further researched. 相似文献56.
57.
58.
59.